They documented impressive responses with statistically significant improvements in laboratory results (methemoglobin, CRP, LDH) and clinical status (rapid reversal of hypoxia and recovery in severely ill COVID-19 subjects) [100,101,102]. The gene discussed is HBG2; the disease is COVID-19.